ZIM Laboratories (NSE:ZIMLAB, BOM:541400) board approved an investment of up to 400,000 euros in its wholly owned subsidiary, SIA ZIM Laboratories, to support business expansion in Europe, according to an Indian bourse filing on Friday.
The company's shareholding in the subsidiary remains unchanged at 100%, the filing said.
Additionally, ZIM Laboratories FZE, a wholly owned subsidiary of ZIM Laboratories, will invest up to 466,000 Emirati Dirham in its step-down subsidiary, ZIM Scientific Office, to support growth in the GCC region, the filing added.
The investment does not alter ZIM Laboratories FZE's full ownership of the entity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.